Healthcare provider profile · identity verified

Joy G Scott, MD

Internal Medicine · WILMORE, KY · NPI 1275572497

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	187	38
Tamsulosin Hcl	Tamsulosin Hcl	142	36
Levothyroxine Sodium	Levothyroxine Sodium	131	31
Eliquis	Apixaban	103	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	14
Furosemide	Furosemide	96	24
Finasteride	Finasteride	94	23
Omeprazole	Omeprazole	91	22
Gabapentin	Gabapentin	81	17
Lisinopril	Lisinopril	79	17
Donepezil Hcl	Donepezil Hcl	77	18
Nystatin	Nystatin	76	suppressed
Sertraline Hcl	Sertraline Hcl	70	20
Metoprolol Tartrate	Metoprolol Tartrate	67	16
Xarelto	Rivaroxaban	59	suppressed
Jardiance	Empagliflozin	56	suppressed
Allopurinol	Allopurinol	55	11
Clopidogrel	Clopidogrel Bisulfate	53	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	suppressed
Mirtazapine	Mirtazapine	50	14
Warfarin Sodium	Warfarin Sodium	45	suppressed
Trazodone Hcl	Trazodone Hcl	44	suppressed
Carvedilol	Carvedilol	41	13
Amlodipine Besylate	Amlodipine Besylate	39	suppressed
Latanoprost	Latanoprost	39	suppressed
Famotidine	Famotidine	38	11
Metformin Hcl	Metformin Hcl	38	11
Potassium Chloride	Potassium Chloride	38	11
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	37	13
Metoprolol Succinate	Metoprolol Succinate	37	suppressed
Montelukast Sodium	Montelukast Sodium	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Tramadol Hcl	Tramadol Hcl	37	suppressed
Memantine Hcl	Memantine Hcl	36	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	34	11
Diclofenac Sodium	Diclofenac Sodium	33	11
Entresto	Sacubitril/Valsartan	28	suppressed
Fluticasone Propionate	Fluticasone Propionate	27	suppressed
Tradjenta	Linagliptin	27	suppressed
Brilinta	Ticagrelor	23	suppressed
Simvastatin	Simvastatin	23	suppressed
Timolol Maleate	Timolol Maleate	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	22	suppressed
Prednisone	Prednisone	22	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	22	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	21	21
Atenolol	Atenolol	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	20	suppressed
Losartan Potassium	Losartan Potassium	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	19	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	19	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	18	suppressed
Ranolazine Er	Ranolazine	18	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Midodrine Hcl	Midodrine Hcl	17	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	17	suppressed
Risperidone	Risperidone	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Buspirone Hcl	Buspirone Hcl	16	suppressed
Citalopram Hbr	Citalopram Hydrobromide	16	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	15	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Nifedipine Er	Nifedipine	15	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Clotrimazole	Clotrimazole	14	suppressed
Glipizide	Glipizide	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Trulicity	Dulaglutide	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	13	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	13	suppressed
Mupirocin	Mupirocin	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Methenamine Hippurate	Methenamine Hippurate	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	11	suppressed
Tizanidine Hcl	Tizanidine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error